Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Biophysical aspects of cyclodextrin interaction with paraoxon.

Soni SD, Bhonsle JB, Garcia GE.

Magn Reson Chem. 2014 Mar;52(3):111-4. doi: 10.1002/mrc.4036. Epub 2013 Dec 19.

PMID:
24357355
2.

Synthesis of 2-substituted beta-cyclodextrin derivatives with a hydrolytic activity against the organophosphorylester paraoxon.

Masurier N, Estour F, Froment MT, Lefèvre B, Debouzy JC, Brasme B, Masson P, Lafont O.

Eur J Med Chem. 2005 Jul;40(7):615-23. Epub 2005 Apr 1.

PMID:
15935896
3.

Characterization, phase-solubility, and molecular modeling of inclusion complex of 5-nitroindazole derivative with cyclodextrins.

Jullian C, Morales-Montecinos J, Zapata-Torres G, Aguilera B, Rodriguez J, Arán V, Olea-Azar C.

Bioorg Med Chem. 2008 May 1;16(9):5078-84. doi: 10.1016/j.bmc.2008.03.026. Epub 2008 Mar 14.

PMID:
18375132
4.

Stereochemistry and dynamics of the inclusion complex of (S)-(+)-fenoprofen with cyclomaltoheptaose (beta-cyclodextrin).

Uccello-Barretta G, Chiavacci C, Bertucci C, Salvadori P.

Carbohydr Res. 1993 Apr 23;243(1):1-10.

PMID:
8324756
5.

Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.

Spamer E, Müller DG, Wessels PL, Venter JP.

Eur J Pharm Sci. 2002 Sep;16(4-5):247-53.

PMID:
12208454
8.

HPLC and 1H-NMR study of chiral recognition in some thromboxane antagonists induced by beta-cyclodextrin.

Casy AF, Cooper AD, Jefferies TM, Gaskell RM, Greatbanks D, Pickford R.

J Pharm Biomed Anal. 1991;9(10-12):787-92.

PMID:
1668300
9.

Melarsoprol-cyclodextrins inclusion complexes.

Gibaud S, Zirar SB, Mutzenhardt P, Fries I, Astier A.

Int J Pharm. 2005 Dec 8;306(1-2):107-21. Epub 2005 Oct 25.

PMID:
16253447
10.
11.

Interaction between beta-cyclodextrin and 1,10-phenanthroline: uncommon 2:3 inclusion complex in the solid state.

Liu Y, Chen GS, Zhang HY, Song HB, Ding F.

Carbohydr Res. 2004 Jun 22;339(9):1649-54.

PMID:
15183740
13.
14.

Improvement of water solubility of sulfamethizole through its complexation with beta- and hydroxypropyl-beta-cyclodextrin. Characterization of the interaction in solution and in solid state.

Pose-Vilarnovo B, Perdomo-López I, Echezarreta-López M, Schroth-Pardo P, Estrada E, Torres-Labandeira JJ.

Eur J Pharm Sci. 2001 Jun;13(3):325-31.

PMID:
11384856
15.

Inclusion complex of fenbufen with beta-cyclodextrin.

Bratu I, Gavira-Vallejo JM, Hernanz A, Bogdan M, Bora G.

Biopolymers. 2004 Mar;73(4):451-6.

PMID:
14991662
16.
17.

Structural background of cyclodextrin-protein interactions.

Aachmann FL, Otzen DE, Larsen KL, Wimmer R.

Protein Eng. 2003 Dec;16(12):905-12.

PMID:
14983070
18.

Investigation of the complexation of (+)-catechin by beta-cyclodextrin by a combination of NMR, microcalorimetry and molecular modeling techniques.

Kríz Z, Koca J, Imberty A, Charlot A, Auzély-Velty R.

Org Biomol Chem. 2003 Jul 21;1(14):2590-5.

PMID:
12956082
19.
20.

Characterization of aqueous and solid inclusion complexes of diuron and isoproturon with beta-cyclodextrin.

Dupuy N, Marquis S, Vanhove G, Bria M, Kister J, Vrielynck L.

Appl Spectrosc. 2004 Jun;58(6):711-8.

PMID:
15198824

Supplemental Content

Support Center